Supplementary Figure 1 from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Bheema Paraselli et al.|Unknown|2023Cited by 0
Supplementary Figure 2 from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0
Supplementary Figure 1 from Biological Characterization of TAK-901, an Investigational, Novel, Multitargeted Aurora B Kinase InhibitorPamela Farrell, Ron de Jong, Lihong Shi et al.|Unknown|2023Cited by 0